(70 days)
The CLEARPLAN EASY Home Pregnancy Test, an over-the-counter (OTC) in vitro diagnostic device, is intended to be used by women to detect pregnancy via a urine test. The CLEARPLAN EASY Home Pregnancy Test is a qualitative test which detects the hormone human chorionic gonadotropin (hCG) in urine. The product will be made available over-the-counter through pharmacies and drug stores.
Not Found
The provided text is a 510(k) premarket notification letter from the FDA for a home pregnancy test. It does not contain information about the acceptance criteria or a study proving the device meets said criteria in the format requested. The document is primarily a regulatory approval letter. Therefore, I cannot extract the detailed information requested in your prompt.
§ 862.1155 Human chorionic gonadotropin (HCG) test system.
(a)
Human chorionic gonadotropin (HCG) test system intended for the early detection of pregnancy —(1)Identification. A human chorionic gonadotropin (HCG) test system is a device intended for the early detection of pregnancy is intended to measure HCG, a placental hormone, in plasma or urine.(2)
Classification. Class II.(b)
Human chorionic gonadotropin (HCG) test system intended for any uses other than early detection of pregnancy —(1)Identification. A human chorionic goadotropin (HCG) test system is a device intended for any uses other than early detection of pregnancy (such as an aid in the diagnosis, prognosis, and management of treatment of persons with certain tumors or carcinomas) is intended to measure HCG, a placental hormone, in plasma or urine.(2)
Classification. Class III.(3)
Date PMA or notice of completion of a PDP is required. As of the enactment date of the amendments, May 28, 1976, an approval under section 515 of the act is required before the device described in paragraph (b)(1) may be commercially distributed. See § 862.3.